What are the next steps if a proton‑pump inhibitor (PPI) fails to relieve reflux symptoms?

Management of PPI-Refractory Reflux Symptoms

If a PPI fails to control reflux symptoms, first optimize to twice-daily dosing for 4-8 weeks, then proceed to endoscopy followed by pH-impedance monitoring off PPI therapy to guide further management. 1

Step 1: Optimize PPI Therapy Before Declaring Failure

• Increase to twice-daily dosing if currently on once-daily therapy, as this is the accepted upper limit of empirical treatment before considering treatment failure 1
• Patients whose heartburn has not adequately responded to twice-daily PPI therapy should be considered treatment failures 1
• A 4-8 week trial of optimized dosing is appropriate before proceeding with diagnostic evaluation 1
• Consider switching to an alternative PPI if side effects (headache, diarrhea, constipation, abdominal pain) are limiting compliance 1

Important caveat: There is no evidence that adding a nocturnal H2RA to twice-daily PPI therapy improves efficacy 1

Step 2: Perform Upper Endoscopy

Endoscopy is the first diagnostic test after PPI failure to evaluate for:

• Barrett's metaplasia, stricture, or esophagitis 1
• Alternative diagnoses: eosinophilic esophagitis (obtain at least 5 esophageal biopsies even with normal-appearing mucosa), peptic ulcer disease, malignancy 1
• Alarm features requiring immediate evaluation: weight loss, dysphagia, epigastric mass 1

Step 3: Esophageal Manometry

After normal endoscopy, perform manometry to: 1

• Localize the lower esophageal sphincter for subsequent pH monitoring
• Evaluate peristaltic function preoperatively if surgery is being considered
• Diagnose subtle presentations of major motor disorders (achalasia, distal esophageal spasm)
• High-resolution manometry has superior sensitivity to conventional manometry for detecting atypical achalasia 1

Step 4: Ambulatory pH-Impedance Monitoring

This is the critical diagnostic test that determines the underlying mechanism of PPI failure:

When to Perform OFF PPI (7 days off therapy):

• Patients WITHOUT previous documented pathological GERD (no prior positive endoscopy or pH testing) 1
• This maximizes detection of excessive acid exposure and symptom-reflux association 1
• This is the preferred approach for most PPI-refractory patients 1

When to Perform ON PPI:

• Patients WITH previous documented pathological GERD (prior erosive esophagitis or positive pH monitoring) 1
• This determines if PPI dose is sufficient and assesses association between persistent acid or non-acid reflux and symptoms 1

Why pH-Impedance Over pH Alone:

pH-impedance monitoring is superior to pH monitoring alone because: 1

• Detects non-acid and weakly acidic reflux (which pH monitoring misses)
• On twice-daily PPI, persistent acid exposure is uncommon (7% with heartburn, 1% with chest pain) 1
• 89% of patients with esophagitis but normal acid exposure have positive symptom association for acid and/or non-acid reflux on impedance 1
• Allows phenotyping: non-erosive reflux disease, hypersensitive esophagus, or functional heartburn 1

Step 5: Management Based on pH-Impedance Results

If Pathological Acid Exposure Persists:

• True PPI failure—consider anti-reflux surgery in carefully selected patients 1
• Ensure medication compliance first 1
• Consider rare causes like Zollinger-Ellison syndrome 1

If Normal Acid Exposure with Positive Symptom-Reflux Association:

• Hypersensitive esophagus—consider neuromodulators, cognitive behavioral therapy 1
• Approximately 60% of non-erosive reflux disease patients refractory to PPI have positive reflux/symptom association, primarily due to non-acid reflux 1

If Normal Acid Exposure with Negative Symptom-Reflux Association:

• Functional heartburn—discontinue PPI, consider alternative therapies 1
• A recent high-quality trial demonstrated that patients with 0 days of acid exposure time >4.0% had 10 times increased odds of successfully discontinuing PPI 2
• Neuromodulators, cognitive behavioral therapy, or hypnotherapy may be beneficial 1

Additional Considerations

For Extraesophageal Symptoms (Chronic Cough, Laryngitis, Asthma):

• Do NOT use empirical PPI therapy for extraesophageal symptoms alone without concomitant typical reflux symptoms 1
• Meta-analyses show no clear benefit of PPIs over placebo for chronic laryngitis or chronic cough 1
• If extraesophageal symptoms occur WITH typical reflux symptoms, twice-daily PPI for 8-12 weeks is reasonable 1
• pH-impedance monitoring off PPI is essential to confirm GERD as the cause before considering anti-reflux surgery 1

Adjunctive Therapies:

• Lifestyle modifications: elevate head of bed, left lateral decubitus sleeping position, avoid food 2-3 hours before bed, weight loss 1
• Alginate-containing antacids may provide additional benefit when added to PPI 1
• Avoid metoclopramide as monotherapy or adjunctive therapy (Grade D recommendation) 1

Anti-Reflux Surgery:

• Only consider in patients with documented pathological GERD (erosive esophagitis and/or excessive acid exposure off PPI) 1
• Requires preserved peristaltic function on manometry 1
• Lack of response to PPI predicts lack of response to surgery—this should be incorporated into shared decision-making 1
• For extraesophageal symptoms, surgical outcomes are variable and less robust than for typical symptoms 1

Common Pitfall:

The most frequent error is continuing to escalate PPI dosing or adding H2RAs without performing objective testing. After twice-daily PPI failure, diagnostic evaluation—not empirical medication adjustments—is the appropriate next step. 1